Raphi Levy - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Reporting relationship: Chief Financial Officer
Issuer ticker: DRTS
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 18:58:57 UTC
Next SEC filing: 04 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Raphael Levy

Key filing fact

Raphi Levy filed Form 3 for Alpha Tau Medical Ltd. (DRTS) on 18 Mar 2026.

Key facts

This page summarizes Raphi Levy's Form 3 filing for Alpha Tau Medical Ltd. (DRTS).
0 reported transactions and 12 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 18:58.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001968095 Primary reporting owner

Levy Raphi

Relationship: Chief Financial Officer
Address: C/O ALPHA TAU MEDICAL, PO BOX 45044, JERUSALEM, ISRAEL
Signature: /s/ Raphael Levy
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRTS holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 180,180
Date: 18 Mar 2026
Ownership: Direct

DRTS holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,996
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

DRTS holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 54,433
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F2

DRTS holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 49,117
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 325,905
Exercise price: $4.03
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 36,212
Exercise price: $4.03
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 45,265
Exercise price: $4.03
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 90,529
Exercise price: $4.03
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 45,265
Exercise price: $4.42
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 86,545
Exercise price: $11.50
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 70,724
Exercise price: $10.92
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 80,360
Exercise price: $7.19
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 328,458
Exercise price: $3.28
Footnotes: F4

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 301,880
Exercise price: $2.98
Footnotes: F5

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 267,641
Exercise price: $2.60
Footnotes: F6

DRTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 158,882
Exercise price: $6.41
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.

Footnote F2

These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.

Footnote F3

These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.

Footnote F4

These are options to acquire ordinary shares, which have fully vested as of the date hereof.

Footnote F5

These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.

Footnote F6

These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.

Footnote F7

These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .